The importance of Qa-1 restricted CD8+ T cells in regulating autoreactive T cell responses has been demonstrated in animal models for autoimmune disorders, including multiple sclerosis (MS).
Objective:
We hypothesize that their human variant, HLA-E restricted CD8+ T cells, fulfills a similar regulatory role in man and that these cells are of importance in MS.
Methods:
A large cohort of MS patients and healthy controls was genotyped for the two known HLA-E polymorphisms. Flow cytometry was used to determine HLA-E expression kinetics and to phenotype HLA-E restricted CD8+ T cells. Immunohistochemistry was performed to investigate HLA-E expression in the central nervous system (CNS) of MS patients.
Results:
HLA-E is upregulated on immune cells upon in vitro activation and this upregulation is polymorphism-dependent for T and B cells. T and B cells in lesions of MS patients show enhanced HLA-E expression. Furthermore, NKG2C+CD8+ T cells of MS patients have a significantly lower Foxp3 expression, while NKG2A+CD8+ T cells of MS patients produce higher levels of pro-inflammatory cytokines compared to those of healthy individuals.
Conclusion:
Our study indicates that the HLA-E system is altered in MS and could play a regulatory role in disease.
SawcerSHellenthalGPirinenM. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature2011; 476: 214–219.
4.
BrouxBHellingsNVenkenK. Haplotype 4 of the multiple sclerosis-associated interleukin-7 receptor alpha gene influences the frequency of recent thymic emigrants. Genes Immun2010; 11: 326–333.
5.
El BehiMRostamiACiricB. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol2010Jun; 5(2): 189–197.
6.
MontesMZhangXBerthelotL. Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin Immunol2009; 130: 133–144.
7.
VigliettaVBaecher-AllanCWeinerHL. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med2004; 199: 971–979.
8.
VenkenKHellingsNHensenK. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. J Neurosci Res2006; 83: 1432–1446.
9.
AbbasAKBenoistCBluestoneJA. Regulatory T cells: Recommendations to simplify the nomenclature. Nat Immunol2013; 14: 307–308.
10.
PietraGRomagnaniCMorettaL. HLA-E and HLA-E-bound peptides: Recognition by subsets of NK and T cells. Curr Pharm Des2009; 15: 3336–3344.
11.
ZaguiaFSaikaliPLudwinS. Cytotoxic NKG2C+ CD4 T cells target oligodendrocytes in multiple sclerosis. J Immunol2013; 190: 2510–2518.
12.
LeeNLlanoMCarreteroM. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A1998; 95: 5199–5204.
13.
O’CallaghanCA. Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors. Microbes Infect2000; 2: 371–380.
14.
ChessLJiangH. Resurrecting CD8+ suppressor T cells. Nat Immunol2004; 5: 469–471.
15.
LuLWerneckMBCantorH. The immunoregulatory effects of Qa-1. Immunol Rev2006; 212: 51–59.
16.
HuDIkizawaKLuL. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol2004; 5: 516–523.
MatteCLacailleJZijenahL. HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group. Hum Immunol2000; 61: 1150–1156.
19.
GorisAWaltonABanM. A Taqman assay for high-throughput genotyping of the multiple sclerosis-associated HLA-DRB1*1501 allele. Tissue Antigens2008; 72: 401–403.
20.
BrouxBPannemansKZhangX. CX3CR1 drives cytotoxic CD4+CD28- T cells into the brain of multiple sclerosis patients. J Autoimmun2012; 38: 10–19.
21.
PurcellSNealeBTodd-BrownK. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet2007; 81: 559–575.
22.
CassellDFormanJ. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes. J Immunol1991; 146: 3–10.
23.
KochSLarbiADerhovanessianE. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing2008; 5: 5–6.
24.
JiangHWareRStallA. Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: A role of the Qa-1 molecule. Immunity1995; 2: 185–194.
25.
JiangHKashlevaHXuLX. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc Natl Acad Sci U S A1998; 95: 4533–457.
26.
PanoutsakopoulouVHusterKMMcCartyN. Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. J Clin Invest2004; 113: 1218–1224.
27.
JagessarSAHeijmansNBlezerEL. Unravelling the T-cell mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG(34–56) peptide in incomplete adjuvant. Eur J Immunol2012; Jan; 42(1): 217–227
28.
PietraGRomagnaniCMazzarinoP. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci U S A2003; 100: 10896–10901.
29.
RomagnaniCPietraGFalcoM. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes. Hum Immunol2004; 65: 437–445.
30.
JiangHCanfieldSMGallagherMP. HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes. J Clin Invest2010; 120: 3641–3650.
31.
MorandiFVenturiCRizzoR. Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation. J Neuroimmune Pharmacol2013Sep; 8(4): 944–955.
WoodKJSawitzkiB. Interferon gamma: A crucial role in the function of induced regulatory T cells in vivo. Trends Immunol2006; 27: 183–187.
34.
HermansGDenzerULohseA. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination. J Autoimmun1999; 13: 233–246.
35.
CorrealeJVillaA. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J Neuroimmunol2008; 195: 121–134.
36.
YaoYHanWLiangJ. Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8(+) regulatory cells. Eur J Immunol2013; 43: 125–136.
